11.01.2013 Views

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

5th EuropEan MolEcular IMagIng MEEtIng - ESMI

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

182<br />

WarSaW, poland May 26 – 29, 2010<br />

P-069 Pyridine-based lanthanide complexes : towards bimodal agents operating as near infrared<br />

luminescent and MRI reporters<br />

Toth E. (1) , Bonnet C. (1) , Villette S. (1) , Suzenet F. (2) , Buron F. (2) , Shade C. (3) , Petoud S. (1) .<br />

(1) Centre de Biophysique Moléculaire, CNRS, Orleans, France<br />

(2) Université d’Orléans, France<br />

(3) University of Pittsburgh, USA<br />

eva.jakabtoth@cnrs-orleans.fr<br />

Introduction: Among the state of the art bioimaging<br />

modalities, some are characterized by high<br />

resolution but low sensitivity (magnetic resonance<br />

imaging, MRI) and others by high sensitivity but<br />

low macroscopic resolution (optical imaging). Luminescent/MRI<br />

bimodal imaging offers the advantage<br />

of combining the high resolution of MRI<br />

with the high sensitivity of luminescence and the<br />

development of contrast agents active for both<br />

techniques is of prime importance. Lanthanides<br />

offer unique opportunity to develop such bimodal<br />

contrast agents given their magnetic and optical<br />

properties. Nevertheless, it was long thought that<br />

the conditions required for both applications were<br />

non-compatible. Here, we report on a versatile pyridine-based<br />

scaffold for Ln 3+ complexation where<br />

MRI and near infrared (NIR) luminescence requirements<br />

are both satisfied using the same ligand.<br />

Methods: The synthesis of the ligands and the complexes<br />

will be briefly described. Potentiometric<br />

titrations have been performed to assess to thermodynamic<br />

stability of the complexes, together<br />

with kinetic measurements to quantify their inertness.<br />

To characterize the MRI properties, the exchange<br />

rate of the water molecules directly bound<br />

the Gd 3+ was determined by measuring 17 O longitudinal<br />

relaxation times. Finally the NIR spectra<br />

of the corresponding Nd 3+ and Yb 3+ were recorded,<br />

as well as the lifetimes of the excited states and the<br />

quantum yield of the complexes to quantify their<br />

luminescent properties.<br />

Results: The bishydrated complexes are found to be<br />

thermodynamically stable and the ligands show a significant<br />

selectivity for Ln 3+ over endogenous cations<br />

such as Zn 2+ , Ca 2+ and Cu 2+ . The kinetic inertness is<br />

also remarkable for such bishydrated complexes. The<br />

chelates do not form ternary complexes with endogenous<br />

donors which does not limit relaxivity in biological<br />

media. All the complexes give rise to NIR emission<br />

and the quantum yields are remarkable. 1 They are in<br />

the same range as those of non-hydrated complexes optimized<br />

for fully protecting the NIR emitting Ln 3+ for<br />

aqueous applications. The modification of the pyridine<br />

into quinoline was successful in shifting the excitation<br />

wavelength of the system towards higher values.<br />

imaging life<br />

Conclusions: The pyridine synthon is a prime candidate<br />

for the development of bimodal NIR/MRI imaging<br />

probes, as the bishydrated Ln 3+ complexes are thermodynamically<br />

and kinetically stable and display a high<br />

NIR quantum yield. The successful modification of the<br />

pyridine into a quinoline did not modify the thermodynamic<br />

properties of the complexes, but it resulted<br />

in a shift of the excitation energy towards lower values<br />

preventing damages to biological samples and allowing<br />

deeper tissue penetration of the excitation photons. The<br />

pyridine platform offers also easy routes for coupling<br />

the probes to biological vectors and optimizing the<br />

MRI properties.<br />

Acknowledgement: This work was financially supported<br />

by the Institut National du Cancer, La Ligue contre<br />

le Cancer, France, and was carried out in the frame of<br />

the COST action D38.<br />

References:<br />

1. L. Pellegatti, J. Zhang, B. Drahos, S. Villette, F. Suzenet,<br />

G. Guillaumet, S. Petoud, E. Toth, Chem. Commun.,<br />

2008, 6591-6593.<br />

2. S. Comby, D. Imbert, C. Vandevyver, J.-C. G. Bünzli,<br />

Chem. Eur. J., 2007, 13, 936.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!